HHS issues fraud alert concerning Dx lab payments to referring physicians; CardioDx wins Aetna coverage for CAD test;

> The Office of Inspector General of the U.S. Department of Health and Human Services has issued a fraud alert regarding how laboratory payments are made to referring physicians. Alert (PDF)

> Sophia Genetics raised $13.75 million in Series B financing designed to boost European adoption of clinical analytics for genetic diseases. Release

> CardioDx, a molecular diagnostics company, has obtained health insurance coverage approvals for its obstructive coronary artery disease test from both Aetna and Coventry Health. Release

> Five Senate Democrats want the White House to release for public comment a long-delayed FDA draft guidance on laboratory developed tests. Story

> Researchers at the Texas A&M Health Science Center College of Medicine, Stanford University and elsewhere have developed a promising new tuberculosis test that is quicker and costs little to use. Item

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

A COVID-19 antibody diagnostic developed through a joint venture between Mount Sinai Health System and RenalytixAI has been authorized by the FDA.

Researchers at Northwestern University have trained an AI algorithm to automatically detect the signs of COVID-19 on a basic X-ray of the lungs.

Hand-held ultrasound developer Butterfly Network is going public through a $1.5 billion acquisition deal backed by Glenview Capital.